Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines

American Journal of Veterinary Research

Volumn 69, Issue 9, 2008, Pages 1197-1202

  Fitzpatrick, Courtney L ^a,c   Farese, James P ^a   Milner, Rowan J ^a   Salute, Marc E ^a   Rajon, Didier A ^b   Morris, Christopher G ^b,d   Bova, Francis J ^b   Lurie, David M ^a   Siemann, Dietmar W ^b  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DOG; DOSE RESPONSE; NONHUMAN; OSTEOSARCOMA CELL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY REPAIR; RADIOSENSITIVITY;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, RADIATION; OSTEOSARCOMA; RADIATION TOLERANCE; TIME FACTORS;

EID: 52649180669     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.9.1197     Document Type: Article

References (35)

1. Dernell WS, Straw RC, Withrow SJ. Tumors of the skeletal system. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders Co, 2001;378-401.
2. Straw RC, Withrow SJ, Powers BE. Management of canine appendicular osteosarcoma. Vet Clin North Am Small Anim Pract 1990; 20:1141-1161.
3. Green EM, Adams WM, Forrest LJ. Four fraction palliative radiotherapy for osteosarcoma in 24 dogs. J Am Anim Hosp Assoc 2002;38:445-451.
4. Ramirez O III, Dodge RK, Page RL, et al. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 1999;40:517-522.
5. McEntee MC, Page RL, Novotney CA, et al. Palliative radiotherapy for canine appendicular osteosarcoma. Vet Radiol Ultrasound 1993;34:367-370.
6. Thrall DE, LaRue SM. Palliative radiation therapy. Semin Vet Med Surg (Small Anim) 1995;10:205-208.
7. Farese JP, Milner R, Thompson MS, et al. Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc 2004;225:1567-1572.
8. McEntee MC. Radiation therapy in the management of bone tumors. Vet Clin North Am Small Anim Pract 1997;27:131-138.
9. Heidner GL, Page RL, McEntee MC, et al. Treatment of canine appendicular osteosarcoma using cobalt 60 radiation and intra-arterial cisplatin. J Vet Intern Med 1991;5:313-316.
10. Withrow SJ, Thrall DE, Straw RC, et al. Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma. Cancer 1993;71:2484-2490.
11. Morello E, Buracco P, Martano M, et al. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs. J Small Anim Pract 2001;42:61-66.
12. MacEwen EG, Kurzman ID. Canine osteosarcoma: amputation and chemoimmunotherapy. Vet Clin North Am Small Anim Pract 1996;26:123-133.
13. Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 1991;5:205-210.
14. Mauldin GN, Matus RE, Withrow SJ, et al. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 1988;2:177-180.
15. Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys 1985;11:87-96.
16. Fertil B, Malaise EP. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys 1981;7:621-629.
17. Bristow RG, Hill RP. Molecular and cellular basis of radiotherapy. In: Tannock I, Hill RP, eds. The basic science of oncology. 3rd ed. New York: McGraw-Hill, Health Professions Division, 1998;308-318.
18. Malaise EP, Fertil B, Chavaudra N, et al. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data. Int J Radiat Oncol Biol Phys 1986;12:617-624.
19. Tucker SL. Is the mean inactivation dose a good measure of cell radiosensitivity? Radiat Res 1986;105:18-26.
20. Hall EJ. Time, dose, and fractionation in radiotherapy. In: Radiobiology for the radiologist. 4th ed. Philadelphia: JB Lippincott, 1994;211-229.
21. Kadosawa T, Nozaki K, Sasaki N. Establishment and characterization of a new cell line from a canine osteosarcoma. J Vet Med Sci 1994;56:1167-1169.
22. Barroga EF, Kadosawa T, Okumura M, et al. Establishment and characterization of the growth and pulmonary metastasis of a highly metastasizing cell line from canine osteosarcoma in nude mice. J Vet Med Sci 1999;61:361-367.
23. Shoieb AM, Hahn KA, Barnhill MA. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS 31) which retain osteoblastic and metastatic properties in nude mice. In Vivo 1998;12:463-472.
24. Munshi A, Hobbs M, Meyn RE. Clonogenic cell survival assay. Methods Mol Med 2005;110:21-28.
25. Weichselbaum RR, Epstein J, Little JB, et al. In vitro cellular radiosensitivity of human malignant tumors. Eur J Cancer 1976;12:47-51.
26. Sugimoto M, Toguchida J, Kotoura Y, et al. Intrinsic radiosensitivity and PLD repair in osteosarcoma cell lines. Int J Radiat Biol 1992;62:469-474.
27. Walter CU, Dernell WS, LaRue SM, et al. Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol 2005;3:1-7.
28. Dibiase SJ, Guan J, Curran WJ, et al. Repair of double-strand breaks and radiosensitivity to killing in an isogenic group of P53 mutant cell lines. Int J Radiat Oncol Biol Phys 1999;45:743-751.
29. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989;246:629-634.
30. Ding HF, Fisher DE. Mechanisms of p53-mediated apoptosis. Crit Rev Oncog 1998;9:83-98.
31. Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci U S A 1993;90:5742-5746.
32. McIlwrath AJ, Vasey PA, Ross GM, et al. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 1994;54:3718-3722.
33. Machak GN, Tkachev SI, Solovyev YN, et al. Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities. Mayo Clin Proc 2003;78:147-155.
34. DeLaney TF, Park L, Goldberg SI, et al. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 2005;60:492-498.
35. Olive PL, Durand RE. Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 1994;13:121-138.